Laurus Labs Limited (LAURUSLABS.NS)
INR 603.85
(-2.2%)
INR 603.85
(-2.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 24.35 Billion INR | 23.68% |
| 2022 | 19.69 Billion INR | 15.76% |
| 2021 | 17.01 Billion INR | 18.7% |
| 2020 | 14.33 Billion INR | 32.98% |
| 2019 | 10.77 Billion INR | 4.34% |
| 2018 | 10.32 Billion INR | 5.74% |
| 2017 | 9.76 Billion INR | 16.39% |
| 2016 | 8.39 Billion INR | -17.42% |
| 2015 | 10.16 Billion INR | 30.46% |
| 2014 | 7.79 Billion INR | 47.63% |
| 2013 | 5.27 Billion INR | 81.88% |
| 2012 | 2.9 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.41 Billion INR | -94.18% |
| 2024 Q2 | 26.78 Billion INR | 1838.45% |
| 2023 FY | 24.35 Billion INR | 23.68% |
| 2023 Q4 | 24.35 Billion INR | 3526.79% |
| 2023 Q2 | 20.67 Billion INR | 4166.59% |
| 2023 Q3 | 671.6 Million INR | -96.75% |
| 2023 Q1 | 484.6 Million INR | -97.54% |
| 2022 Q3 | 521.9 Million INR | -97.45% |
| 2022 Q4 | 19.69 Billion INR | 3673.56% |
| 2022 Q1 | 759.4 Million INR | -95.54% |
| 2022 FY | 19.69 Billion INR | 15.76% |
| 2022 Q2 | 20.44 Billion INR | 2592.9% |
| 2021 Q1 | 484.6 Million INR | -96.62% |
| 2021 Q4 | 17.01 Billion INR | 4299.56% |
| 2021 Q3 | 386.7 Million INR | -97.76% |
| 2021 Q2 | 17.26 Billion INR | 3462.22% |
| 2021 FY | 17.01 Billion INR | 18.7% |
| 2020 Q3 | 21.9 Million INR | -99.8% |
| 2020 FY | 14.33 Billion INR | 32.98% |
| 2020 Q4 | 14.33 Billion INR | 65344.29% |
| 2020 Q2 | 10.8 Billion INR | 62013.79% |
| 2020 Q1 | 17.4 Million INR | -99.84% |
| 2019 Q2 | 11.4 Billion INR | 37640.98% |
| 2019 FY | 10.77 Billion INR | 4.34% |
| 2019 Q1 | 30.21 Million INR | -99.71% |
| 2019 Q3 | 48.33 Million INR | -99.58% |
| 2019 Q4 | 10.77 Billion INR | 22199.63% |
| 2018 Q4 | 10.32 Billion INR | 11220.12% |
| 2018 FY | 10.32 Billion INR | 5.74% |
| 2018 Q2 | 11.83 Billion INR | 38630.16% |
| 2018 Q1 | 30.57 Million INR | -99.69% |
| 2018 Q3 | 91.25 Million INR | -99.23% |
| 2017 FY | 9.76 Billion INR | 16.39% |
| 2017 Q2 | 10.42 Billion INR | 25384.38% |
| 2017 Q3 | 54.76 Million INR | -99.47% |
| 2017 Q4 | 9.76 Billion INR | 17739.72% |
| 2017 Q1 | 40.91 Million INR | -99.51% |
| 2016 Q4 | 8.39 Billion INR | 0.0% |
| 2016 FY | 8.39 Billion INR | -17.42% |
| 2016 Q2 | 11.1 Billion INR | 3760.18% |
| 2016 Q1 | 287.74 Million INR | 0.0% |
| 2015 FY | 10.16 Billion INR | 30.46% |
| 2014 FY | 7.79 Billion INR | 47.63% |
| 2013 FY | 5.27 Billion INR | 81.88% |
| 2012 FY | 2.9 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Lupin Limited | 19.38 Billion INR | -25.652% |
| Sigachi Industries Limited | 859.94 Million INR | -2732.435% |
| Innova Captab Limited | 2.33 Billion INR | -943.702% |
| Ind-Swift Limited | 9.5 Billion INR | -156.163% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -638.34% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -559.505% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | -142.803% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 585.941% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -2396.129% |
| Morepen Laboratories Limited | -231.17 Million INR | 10636.436% |
| Sequent Scientific Limited | 4.17 Billion INR | -482.906% |
| Wanbury Limited | 1.1 Billion INR | -2102.555% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -295.587% |
| Aarti Drugs Limited | 5.54 Billion INR | -339.0% |
| Gufic Biosciences Limited | 3.19 Billion INR | -662.526% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 956.856% |
| Alembic Limited | 66.9 Million INR | -36308.819% |
| Hikal Limited | 7.96 Billion INR | -205.73% |
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -530.06% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 668.402% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 2311.704% |
| Themis Medicare Limited | 764.96 Million INR | -3084.145% |
| RPG Life Sciences Limited | -364.7 Million INR | 6778.777% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 9890.307% |
| Vaishali Pharma Limited | 119.13 Million INR | -20345.293% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -832.559% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 1852.426% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 10.027% |
| FDC Limited | -57.75 Million INR | 42276.029% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -20191.322% |
| Eris Lifesciences Limited | 13.8 Billion INR | -76.422% |
| Windlas Biotech Limited | -273.04 Million INR | 9020.854% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 133.61% |
| Venus Remedies Limited | -267.7 Million INR | 9198.805% |
| ZIM Laboratories Limited | 983.6 Million INR | -2376.352% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 19183.267% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 6745.268% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 542.244% |
| Shilpa Medicare Limited | 9.06 Billion INR | -168.564% |
| Orchid Pharma Limited | -1.31 Billion INR | 1953.91% |
| Albert David Limited | -278.36 Million INR | 8850.076% |
| Hester Biosciences Limited | 2.29 Billion INR | -963.303% |
| Sakar Healthcare Limited | 790.93 Million INR | -2979.575% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -16701.057% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 1137.372% |
| Divi's Laboratories Limited | -39.77 Billion INR | 161.246% |
| Mankind Pharma Limited | -1.74 Billion INR | 1493.17% |
| Neuland Laboratories Limited | -214.05 Million INR | 11478.925% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -763.374% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -522.635% |
| Wockhardt Limited | 18.27 Billion INR | -33.32% |
| Bal Pharma Limited | 1.26 Billion INR | -1827.687% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | -88.628% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 2203.862% |
| Alkem Laboratories Limited | -1.6 Billion INR | 1613.452% |
| Valiant Laboratories Limited | 649.9 Million INR | -3647.873% |
| Ajanta Pharma Limited | -954.9 Million INR | 2650.791% |
| Unichem Laboratories Limited | 931.91 Million INR | -2513.701% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -10493.303% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 132147.598% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -8085.214% |
| Granules India Limited | 9.28 Billion INR | -162.281% |
| Medicamen Biotech Limited | 160.31 Million INR | -15093.43% |
| Medico Remedies Limited | 78.67 Million INR | -30858.857% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 686.496% |
| Ipca Laboratories Limited | 11.41 Billion INR | -113.378% |
| Brooks Laboratories Limited | 49.48 Million INR | -49121.986% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -52609.312% |
| Piramal Enterprises Limited | 491.39 Billion INR | 95.043% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 23.476% |
| NATCO Pharma Limited | -5.81 Billion INR | 518.73% |
| Suven Life Sciences Limited | -1.63 Billion INR | 1591.856% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1160.139% |
| Strides Pharma Science Limited | 23.25 Billion INR | -4.732% |
| Indoco Remedies Limited | 6.47 Billion INR | -276.102% |
| Alpa Laboratories Limited | 35.36 Million INR | -68778.489% |
| Lasa Supergenerics Limited | 205.79 Million INR | -11735.577% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 2686.271% |